Slingshot Insights | Eigr Overview

EIGR Overview

Upcoming Projects (EIGR)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (EIGR)

A Third Opinion: Discussing the standard of care and/or the potential of Eiger's investigational agent (Peginterferon Lambda) to significantly decrease COVID-19 related hospitalizations or deaths in predominantly vaccinated populations
Ticker: EIGR
Executed On: Sep 08, 2023 at 12:00 PM EDT
A Second Opinion: Discussing the standard of care and/or the potential of Eiger's investigational agent (Peginterferon Lambda) to significantly decrease COVID-19 related hospitalizations or deaths in predominantly vaccinated populations
Ticker: EIGR
Executed On: Aug 25, 2023 at 12:00 PM EDT
Discussing the standard of care and/or the potential of Eiger's investigational agent (Peginterferon Lambda) to significantly decrease COVID-19 related hospitalizations or deaths in predominantly vaccinated populations
Ticker: EIGR
Executed On: Aug 24, 2023 at 04:00 PM EDT
The current treatment landscape for HDV and new therapies in development including Lonafarnib in development from Eiger Bio and Bulevirtide by Gilead Sciences which was recently rejected by the FDA
Tickers: EIGR, GILD
Executed On: Dec 12, 2022 at 05:00 PM EST
Discussing therapies in development for HDV with a focus on Eiger's lonafarnib
Ticker: EIGR
Executed On: Jan 18, 2022 at 04:00 PM EST

Upcoming & Overdue Catalysts (EIGR)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (EIGR)

Don’t see a strategic initiative related to the company you care about? Create your own!